Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestyramine for POPs reduction in obese women
NCT05966727Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Open-label, single-arm trial of cholestyramine, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Serum persistent organic pollutants concentrations at 19 months. Started Mar 2025; status: recruiting.
02
Drugs
cholestyramine
Beyond the preview
Go deeper on NCT05966727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05966727.